Full Year 2020 Nova Eye Medical Ltd Earnings Call Transcript
Thank you for standing by, and welcome to the Nova Eye Medical FY '20 Investor Conference Call. (Operator Instructions)
I would now like to hand the conference over to Tom Spurling, Director of the company. Please go ahead.
Thank you. Good morning, everyone. Thanks for taking the time to listen to our story. As the introduction, I'm pleased to be appointed this morning as a Director of Nova Eye and Victor Previn is with me. I will lead the discussion, but please feel free to ask questions at the end for both me or Victor.
If we could just kick off on Page 3. Obviously, the divestment of our Capital Equipment business for $100 million was a big focus over the last 12 months. And we now have a company that can focus on the fastest-growing segment of the ophthalmic market that is consumable surgical devices for glaucoma disease management. That is our primary focus. On the 31st of July or 2nd of July, we announced at 31st of July, we completed the acquisition of Molteno, a
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |